Striatal dopamine output is compromised within +/- BDNF mice

Synapse

Volumn 43, Issue 2, 2002, Pages 112-117

  Dluzen, Dean E ^a,b   Anderson, Linda I ^a,b   McDermott, Janet L ^a   Kucera, Jan ^a,b   Walro, Jon M ^a  

^a Northeast Ohio Medical University   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Methamphetamine; Neurodegeneration; Neurotoxicity; Nigrostriatal system; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; METHAMPHETAMINE; POTASSIUM ION;

ALLELE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; GENOTYPE; HETEROZYGOSITY; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DRUG INTERACTIONS; EXTRACELLULAR SPACE; FEMALE; GENOTYPE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOSTRIATUM; NEURAL PATHWAYS; NEURONS; PARKINSONIAN DISORDERS; PERFUSION; POTASSIUM; SUBSTANTIA NIGRA;

EID: 0036137088     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10027     Document Type: Article

References (44)

1. Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor
2. BDNF gene transcripts in mesencephalic neurons and its differential regulation by NMDA
3. The nature of trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture
4. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1 and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture
5. Lntr receptors
6. MPP+-induced mitochondrial dysfunction is potentiated by dopamine
7. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in normal adult rat CNS: Evidence for anterograde axonal transport
8. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4
9. Use of in vitro superfusion to assess the dynamics of striatal dopamine: Influence of estrogen
10. Age-related changes in monoamines within the olfactory bulbs of the Fischer 344 male rat
11. Effects of orchidectomy on nigrostriatal dopaminergic function: Behavioral and physiological evidence
12. Daily spontaneous running alters behavioral and neurochemical indices of nigrostriatal function
13. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice
14. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice
15. Mice lacking brain derived neurotrophic factor develop with sensory deficits
16. Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons
17. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter
18. Brain-derived and glial cell line derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death
19. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain
20. Rat fetal mesencephalon grown as solid tissue cultures: Influence of culture time and BDNF treatment on dopamine neuron survival and function
21. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
22. Reduced BDNF expression in the Parkinson's disease substantia nigra
23. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
24. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon
25. Age related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: A comparison to those of nerve growth factor and neurotrophin-3
26. NGF, BDNF, and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals
27. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3
28. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection
29. Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor
30. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF
31. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine
32. Brain-derived growth factor and nerve growth factor concentrations are decreased in substantia nigra in Parkinson's disease
33. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum
34. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
35. Neurochemical neutralization of methamphetamine with high affinity nonselective inhibitors of biogenic amine transporters: A pharmacological strategy for treating stimulant abuse
36. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons
37. Differences in release and clearance of extracellular dopamine in the striatum after spontaneous or GM1-ganglioside-stimulated recovery from experimental parkinsonism
38. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury
39. Effects of BDNF on dopaminergic, serotonergic and GABAergic neurons in cultures of fetal ventral mesencephalon
40. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and n-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system
41. Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain
42. Differential expression of GDNF, BDNF and NT-3 in the aging nigrostriatal system following a neurotoxic lesion
43. The response of human and rat fetal mesencephalon in culture to the brain-derived neurotrophic factor treatment
44. Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion